Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.49 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.45 |
| ▸ | ASPH | Q12797 | 1/20 | 0.45 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.45 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | PREP | P48147 | 2/20 | 0.44 |
| ▸ | FAP | Q12884 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1651905 | 0.95 | EPHX1 (0.55) | ALDH1A1USP2HPGDEPHX1MTNR1A | |
| SCHEMBL15865900 | 0.93 | EPHX1 (0.59) | ALDH1A1USP2HPGDEPHX1SMN1; SMN2 | |
| SCHEMBL1449384 | 0.93 | EPHX1 (0.59) | ALDH1A1USP2HPGDEPHX1SMN1; SMN2 | |
| SCHEMBL1653856 | 0.91 | KMT2A (0.50) | ALDH1A1USP2HPGDEPHX1MTNR1A | |
| SCHEMBL1651858 | 0.83 | AAK1 (0.41) | ALDH1A1USP2HPGDEPHX1MTNR1A | |
| SCHEMBL27758181 | 0.81 | GNAI3 (0.51) | ALDH1A1SMN1; SMN2BBOX1ASPHKDM8 | |
| SCHEMBL30393917 | 0.81 | HDAC1 (0.40) | ALDH1A1USP2HPGDEPHX1SMN1; SMN2 | |
| SCHEMBL1651189 | 0.81 | HSD11B1 (0.43) | EPHX1SMN1; SMN2HSD17B10BBOX1ASPH | |
| SCHEMBL26583876 | 0.80 | EPHX1 (0.48) | ALDH1A1USP2HPGDEPHX1MTNR1A | |
| Hydrochloric Acid SCHEMBL8838153 | 0.79 | GNAI3 (0.54) | ALDH1A1SMN1; SMN2PREPHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4764888-B2 | — | — | 2011-09-07 | — | — | JP | claimed |
| EP-1868982-A2 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | The Governors of the University of Alberta (CA) | 2007-12-26 | — | — | EP | claimed |
| WO-2006117686-A2 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2006-11-09 | — | — | WO | claimed |
| US-20060205811-A1 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2006-09-14 | — | — | US | claimed |
| US-20060173208-A1 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2006-08-03 | — | — | US | claimed |
| US-20050182133-A1 | Compounds that stimulate glucose utilization and methods of use | UNIVERSITY OF ALBERTA (CA) | 2005-08-18 | — | — | US | claimed |
| EP-1499580-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | UNIVERSITY OF ALBERTA (CA) | 2005-01-26 | — | — | EP | claimed |
| US-20040116517-A1 | Compounds that stimulate glucose utilization and methods of use | UNIVERSITY OF ALBERTA (CA) | 2004-06-17 | — | — | US | claimed |
| WO-2003082800-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | THE UNIVERSITY OF ALBERTA (CA) | 2003-10-09 | — | — | WO | claimed |
| US-20030191182-A1 | Compounds that stimulate glucose utilization and methods of use | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE (CA) | 2003-10-09 | — | — | US | claimed |
| US-20230046065-A1 | MERGING C(sp3)-H ACTIVATION WITH DNA-ENCODING | THE SCRIPPS RESEARCH INSTITUTE | 2023-02-16 | — | — | US | disclosed |
| WO-2021108411-A1 | MERGING C(SP3)-H ACTIVATION WITH DNA-ENCODING | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-06-03 | — | — | WO | disclosed |
| EP-1868982-B1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | UNIV ALBERTA (CA) | 2015-04-29 | — | — | EP | disclosed |
| US-8202901-B2 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2012-06-19 | — | — | US | disclosed |
| US-8202901-B2 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2012-06-19 | — | — | US | disclosed |
| US-20050182133-A1 | Compounds that stimulate glucose utilization and methods of use | UNIVERSITY OF ALBERTA (CA) | 2005-08-18 | — | — | US | disclosed |
| EP-1499580-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | UNIVERSITY OF ALBERTA (CA) | 2005-01-26 | — | — | EP | disclosed |
| US-20040116517-A1 | Compounds that stimulate glucose utilization and methods of use | UNIVERSITY OF ALBERTA (CA) | 2004-06-17 | — | — | US | disclosed |
| WO-2003082800-A1 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | THE UNIVERSITY OF ALBERTA (CA) | 2003-10-09 | — | — | WO | disclosed |
| US-20030191182-A1 | Compounds that stimulate glucose utilization and methods of use | GOVERNORS OF THE UNIVERSITY OF ALBERTA, THE (CA) | 2003-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182133-A1 | Compounds that stimulate glucose utilization and methods of use | GPR119, SLC2A4, SLC2A1 | ALDH1A1 1918/4885USP2 4500/4885HPGD 790/4885 |
| US-20060173208-A1 | Compounds that stimulate glucose utilization and methods of use | GPR119, SLC2A4, SLC2A1 | ALDH1A1 1990/4885USP2 4491/4885HPGD 709/4885 |
| US-20060205811-A1 | Compounds that stimulate glucose utilization and methods of use | GPR119, SLC2A4, SLC2A1 | ALDH1A1 1990/4885USP2 4491/4885HPGD 709/4885 |
| US-20030191182-A1 | Compounds that stimulate glucose utilization and methods of use | GPR119, SLC2A3, CYCS | ALDH1A1 2045/4885USP2 3821/4885HPGD 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.